Company Navana Pharmaceuticals PLC

NAVANAPHAR

BD0497NAVPH5

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 10/06/2024 BST			5-day change	1st Jan Change
88.2 ^BDT	+2.56%		-2.86%	+4.50%

05-13	Navana Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
02-07	Navana Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Navana Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company. The Company is engaged in manufacturing, marketing, and distribution of pharmaceutical products for human and animal health products and sales of the produced items in the domestic and foreign market. The Company is engaged in manufacturing, marketing and distribution of generic pharmaceuticals finished products, which includes human drugs dosages form like tablet, capsule, powder for suspension, cream, ointment, powder, injection, eye and nasal drop, liquid, sachet products, oral solution, veterinary drugs dosages form like vaccine, bolus, liquid, injection, water soluble powder and premix. Its products include Alleloc DS, Duracef, Nafgal, L-Amlo, Navix, Nestor, Tabis, Tabis plus, Imigra, Pizofen, Pregan, Dextac Capsule, Joytrip Chewable Tablet, Prulicon Tablet, Toma, Odafen, Desatrol, Arokast, Bonacerin, Azirox, Esona, Clonipres, Meltix, Diplin, among others.

Number of employees: 4,143

Managers	Title	Age	Since
Mohammad Shafiq CEO	Chief Executive Officer	63	24/11/20
Mohammed Abu Hurayra DFI	Director of Finance/CFO	42	24/03/13
Javed Kaiser Ally DFI	Director of Finance/CFO	54	24/11/20
Arshadul Hoque Chowdhury ADM	Chief Administrative Officer	44	06/04/13
Malay Kumar Dey CTO	Chief Tech/Sci/R&D Officer	39	14/11/20
Shamim Rabbani COO	Chief Operating Officer	64	30/09/20
Sayeed Ahmed BRD	Director/Board Member	46	24/11/20
Sanjoy Banik PRN	Corporate Officer/Principal	49	30/06/14
Mohammad Shaheenur Rahman PRN	Corporate Officer/Principal	56	03/10/20
Manik Chandra Paul PRN	Corporate Officer/Principal	44	03/10/20

Members of the board	Title	Age	Since
Anisuzzaman Chowdhury CHM	Chairman	51	11/02/20
Mohammad Shafiq CEO	Chief Executive Officer	63	24/11/20
Imrana Zaman Chowdhury BRD	Director/Board Member	44	24/11/20
Javed Kaiser Ally DFI	Director of Finance/CFO	54	24/11/20
Sayeed Ahmed BRD	Director/Board Member	46	24/11/20
Zahara Rasul BRD	Director/Board Member	50	24/11/20
Tarana Ahmed BRD	Director/Board Member	45	24/11/20
Masuma Parvin BRD	Director/Board Member	56	24/12/20
Khondaker Sabbir Kabir BRD	Director/Board Member	57	05/09/21
Mohammad Arife Billah BRD	Director/Board Member	41	05/09/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	107,416,217	106,342,055 ( 99.00 %)	0	99.00 %

Name	Equities	%	Valuation
Anissa Zaman 9.216 %	9,899,890	9.216 %	8 M BDT
Investcorp Investment Advisers LLC 8.113 %	8,714,953	8.113 %	7 M BDT
Masuma Parvin 7.350 %	7,894,891	7.350 %	6 M BDT
Mohammad Shafiq 6.738 %	7,237,230	6.738 %	6 M BDT
Nmi Holdings Ltd. 5.228 %	5,616,110	5.228 %	4 M BDT
Montenia Holdings Ltd. 5.165 %	5,548,039	5.165 %	4 M BDT
Zahara Rasul 4.482 %	4,814,810	4.482 %	4 M BDT
Imrana Zaman Chowdhury 3.737 %	4,014,010	3.737 %	3 M BDT
Anisuzzaman Chowdhury 3.737 %	4,014,010	3.737 %	3 M BDT
Sayeed Ahmed 2.460 %	2,642,640	2.460 %	2 M BDT

Navana Pharmaceuticals Plc

House 99, Road 4 Block B

1213, Banani

http://www.navanapharma.com

address Navana Pharmaceuticals PLC(NAVANAPHAR)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
NAVANA PHARMACEUTICALS PLC	+4.50%	78.59M
ELI LILLY AND COMPANY	+48.53%	779B
NOVO NORDISK A/S	+40.67%	631B
JOHNSON & JOHNSON	-6.37%	354B
MERCK & CO., INC.	+20.93%	333B
ABBVIE INC.	+8.21%	301B
ASTRAZENECA PLC	+16.75%	249B
ROCHE HOLDING AG	-1.19%	216B
NOVARTIS AG	+10.85%	214B
AMGEN INC.	+4.40%	163B

Other Pharmaceuticals